Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants
Colorectal Cancer
About this trial
This is an interventional screening trial for Colorectal Cancer focused on measuring colon cancer, rectal cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Healthy participants Eligible for colorectal cancer screening No personal or family history of colorectal cancer No more than 1 first-degree relative who has had colorectal cancer Part 1: Has not undergone regular screening for colorectal cancer Part 2: Not currently undergoing regular colon cancer testing, including any of the following: Fecal occult blood testing within the past year Flexible sigmoidoscopy or colonoscopy within the past 5 years PATIENT CHARACTERISTICS: Age 50 to 74 Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal Not specified Other No inflammatory bowel disease (part 1 only) No concurrent health issues that would preclude study participation (part 1 only) No history of cancer except basal cell or squamous cell skin cancer (part 2 only) Able to speak and read English (part 2 only) PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy Not specified Endocrine therapy Not specified Radiotherapy Not specified Surgery Not specified
Sites / Locations
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
- Fox Chase Cancer Center
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center